8) Nerve Agent Prophylaxis/Pretreatments
Abstract
Exposure to nerve agents is at worst catastrophic and at best disabling for an extended period – and in most cases the onset of symptoms is very fast. Nerve agents work by blocking the signal flow across nerve junctions, ultimately resulting in a loss of ability to control both voluntary and involuntary muscles and death by asphyxiation. Maintaining full mission readiness in a CB contested environment would require advance administration of a medical antidote well before exposure and would not require additional treatment after exposure (prophylaxis). Until now, no such antidote has existed. The nerve agent (NA) prophylaxis portfolio is developing protective medicines that are effective against a broader range of nerve agents – including fourth generation agents – than had ever before been thought possible. Successful development of these medicines will greatly enhance the ability of the Warfighter to stay in the fight and move forward.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2025
- Source ID
- 6edaf497d1dfad37eab7cf3bd073d38b